NCT01721967View on ClinicalTrials.gov

Ranolazine for the Treatment of Chest Pain in HCM Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

May 31, 2016

Conditions

Hypertrophic Cardiomyopathy

Interventions

DRUG

Ranolazine

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Duke University

OTHER

NCT01721967 - Ranolazine for the Treatment of Chest Pain in HCM Patients | Biotech Hunter | Biotech Hunter